Référentiel des médicaments
Telotristat etiprate
Telotristat etiprate is a medicine in the class gastrointestinal tract. It is used for diarrhea.
- Classe médicamenteuse: Gastrointestinal Tract
- Indications: diarrhea
Dernière mise à jour Sources: EMA SmPC
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
L'essentiel
- Classe médicamenteuse
- Gastrointestinal Tract
- Interactions connues
- 12 (Modérée: 10 · Mineure: 2)
- Noms commerciaux
- 1
- Pays et marchés
- 1
Indications
Mécanisme d'action
Telotristat ethyl and its active metabolite telotristat inhibit L-tryptophan hydroxylases (TPH1 and TPH2), the rate-limiting steps in serotonin biosynthesis. By inhibiting peripheral TPH1 it reduces serotonin production and eases carcinoid syndrome symptoms.
Posologie adulte habituelle (résumé de la notice)
Carcinoid syndrome diarrhoea (with somatostatin analogue therapy, adults inadequately controlled by SSA): 250 mg orally three times daily; higher doses not recommended; reassess benefit if no response within 12 weeks
Grossesse et allaitement
- Grossesse
- Unknown No human data. No fetal effects in rats at 9 times human exposure; in rabbits fetal loss only with maternal toxicity (15 times), and more early pup deaths in rats at 5 times. EU: not recommended in pregnancy or without contraception. Avoid; use adequate contraception.
- Allaitement
- Unknown No human or animal milk data; no LactMed record. EU label: should not be used while breastfeeding (risk cannot be excluded); US label: weigh benefits and watch the infant for constipation. Avoid if possible.
Effets indésirables signalés
- Abdominal pain
- Gamma-glutamyl transferase increased
- Fatigue
- Abdominal distension
- Flatulence
- Constipation
Contre-indications
- Hypersensitivity to the active substance or to any excipients.
Précautions particulières
- Hepatic enzyme elevations: monitor liver enzymes before and during therapy as clinically indicated; discontinue if liver injury is suspected and do not resume unless another cause is found.
- Constipation: telotristat reduces bowel movement frequency; monitor for constipation and re-evaluate therapy if it develops.
- Depressive disorders: depression, depressed mood and decreased interest reported; patients should report symptoms.
Informez votre pharmacien ou votre médecin en cas de grossesse ou d'allaitement, de maladie rénale ou hépatique, d'allergies, ainsi que de tout autre médicament ou complément que vous prenez.
Principales interactions (12)
- Bupropion + Telotristat etiprate Moderate
- Capecitabine + Telotristat etiprate Moderate
- Everolimus + Telotristat etiprate Moderate
- Flutamide + Telotristat etiprate Moderate
- Irinotecan + Telotristat etiprate Moderate
- Midazolam + Telotristat etiprate Moderate
- Octreotide + Telotristat etiprate Moderate
- Prasugrel + Telotristat etiprate Moderate
- Simvastatin + Telotristat etiprate Moderate
- Sodium valproate + Telotristat etiprate Moderate
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour ouvrir la monographie complète de Telotristat etiprate : posologie, grossesse et allaitement, effets indésirables, mises en garde et toutes les interactions.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
Essayez Pro+ gratuitement pendant 7 jours sur le web. Sans carte.
Questions fréquentes
What is Telotristat etiprate used for?
Telotristat etiprate is a medicine in the class gastrointestinal tract. It is used for Diarrhea.
What side effects have been reported with Telotristat etiprate?
Abdominal pain, Gamma-glutamyl transferase increased, Fatigue, Abdominal distension, Flatulence, Constipation.
Can Telotristat etiprate be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. No human data. No fetal effects in rats at 9 times human exposure; in rabbits fetal loss only with maternal toxicity (15 times), and more early pup deaths in rats at 5 times. EU: not recommended in pregnancy or without contraception. Avoid; use adequate contraception. Breastfeeding: Unknown. No human or animal milk data; no LactMed record. EU label: should not be used while breastfeeding (risk cannot be excluded); US label: weigh benefits and watch the infant for constipation. Avoid if possible.
What does Telotristat etiprate interact with?
MediHelp lists 12 known interactions for Telotristat etiprate. Moderate: 10 · Minor: 2. The most serious include Bupropion, Capecitabine, Everolimus.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
